Great to be in Vancouver for the @smallcapdisc conference to tell the @AuxlyGroup story and spend some time with investors who are taking a closer look at what we're building.
If you are interested in Auxly, please check out our presentation.
$cbwtf$xly.to
Really enjoyed my conversation with @jesseredmond and @MorganPaxhia on @higherexchanges.
We covered a lot of ground, including how @Auxly built #1 cannabis brand in Canada, our world-class assets and capabilities and why we believe we're just getting started.
$cbwtf$XLY.TO
Delighted to see Acumen initiate coverage of @AuxlyGroup. Proud of what our team has built and pleased to see growing recognition of our market leadership, financial performance and long-term growth opportunities. We're just getting started! $cbwtf$xly.to
$XLY.TO$CBWTF Acumen Capital initiates coverage of Auxly Cannabis Group with a $5.00/share Price Target. 👏
''Valuation: Auxly currently trades at 6.5x 2026E and 5.4x 2027E EV/Adj. EBITDA versus the peer group average at 9.7x and 7.0x respectively.''
Grateful and humbled to have great shareholders who believe in what we are building at @AuxlyGroup.
Thank you Mathieu and the Rivemont team! 🙏🙏
Building to last $cbwtf$xly.to
The tweet below will be 1 year old tomorrow. In hindsight, two of the three calls were pretty solid!
$DBO.TO $0.31 -> $1.12 (+ 261%)
$TRBR.V $0.86 -> Acquired for $1.64 (+ 91%)
$COV.V $2.62 -> $2.11 (- 19%)
If there's one stock to watch this August, I believe it's Auxly Cannabis Group $XLY.TO$CBWTF.
Auxly is one of the best Canadian LPs on almost any metric. Retail POS data shows their retail sales grew 20% yoy in Q2 in a flat overall market (+0.6% yoy) = Auxly is massively gaining market share. This isn't a one-off, btw. They've been gaining market share for 10+ quarters.
At $0.185/share, the stock trades at 6x my 2026 EBITDA forecast while peers trade at 8x on average (the whole industry is still heavily discounted, but this is another topic).
The company is aggressively buying back shares and has just announced a 14:1 share consolidation to improve its capital markets profile and appeal to institutional investors.
A company growing double-digits, with operating leverage (profitability grows faster than revenue), shrinking its share count and trading at 6x EBITDA looks like a great setup to me. The market is totally asleep on this one.
Disclaimer: This is my opinion and should not be construed as investment advice or a recommendation. I am the Portfolio Manager and a unitholder of the Rivemont MicroCap Fund. The fund is a shareholder of Auxly Cannabis Group (TSX: XLY).
Results of Annual General and Special Meeting of Shareholders: in addition to standard AGM matters, shareholders also authorized the Board to amend the articles of the Company to effect a consolidation of common shares of up to 20:1. $XLY.TO$CBWTFow.ly/yXKf50ZjBIb
Our Q1 shareholder letter is live and I encourage all shareholders to read it.
Strong results, disciplined capital allocation, and a clear plan to improve our market quality.
Building to last. $xly.to$cbwtf
Proud of the @AuxlyGroup team for another strong quarter of YoY growth! Q1: Net Revenue +22%, EBITDA +65%, Cash Flow +102%. Building to last. $cbwtf$xly.to
$XLY.TO – New Position
Needed to swap out $LOVE.TO when they became a client of the firm, $XLY.TO is the next best thing asides from $ROMJ.V maybe which is also a client. Pretty monster Q4 and 2025 with a muted reaction on the stock, used this to buy more. Nice insider buying lately. Generating lots of cash flow, solid growth. Very cheap given the sector sentiment at 4x 2026 EBITDA. 14% FCF yield on 2025 numbers. @maxwellhouse99
"There was a big boom, then bust. A lot of people got burned," says @Stocks_Stones of the marijuana stocks
In the last 18 months he's been picking up the broken pieces.
Tune in to find out which stocks he's buying
inthemoneypod.com/podcast/ma…